Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1525 of 3546 entries
View as:

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Phase: N/A Priority: Normal
NCT ID: NCT01495026 Org: User:
Start: 11/06/11 End: 04/03/12 Due: 04/03/13

A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate

Phase: N/A Priority: Normal
NCT ID: NCT02184637 Org: User:
Start: 07/31/14 End: 04/08/15 Due: 04/08/16

A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites.

Phase: N/A Priority: Normal
NCT ID: NCT00468897 Org: User:
Start: 03/21/07 End: 05/02/07 Due: 05/02/08

Burden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in France

Phase: N/A Priority: Normal
NCT ID: NCT02487472 Org: User:
Start: 01/19/16 End: 08/28/17 Due: 08/28/18

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

Phase: N/A Priority: Normal
NCT ID: NCT00116844 Org: User:
Start: 03/29/05 End: 01/10/06 Due: 01/10/07

Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix

Phase: N/A Priority: Normal
NCT ID: NCT00693706 Org: User:
Start: 06/02/08 End: 03/26/09 Due: 03/26/10

A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05276297 Org: User:
Start: 03/22/22 End: 08/11/25 Due: 08/11/26

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05630846 Org: User:
Start: 12/14/22 End: 10/14/24 Due: 10/14/25

A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT06806137 Org: User:
Start: 05/15/25 End: 04/02/27 Due: 04/02/28

GW679769 In Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT00264628 Org: User:
Start: 10/31/05 End: 09/30/06 Due: 09/30/07

Study in Mild Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00748306 Org: User:
Start: 12/31/08 End: 09/30/09 Due: 09/30/10

A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT02202161 Org: User:
Start: 08/27/14 End: 01/30/15 Due: 01/30/16

Depression Study In Elderly Patients

Phase: N/A Priority: Normal
NCT ID: NCT00067444 Org: User:
Start: 06/30/03 End: 01/31/05 Due: 01/31/06

A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00224497 Org: User:
Start: 09/30/05 End: - Due: -

Special Drug Use Investigation for ROTARIX®

Phase: N/A Priority: Normal
NCT ID: NCT01636739 Org: User:
Start: 07/31/12 End: 08/31/15 Due: 08/31/16

Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT00518336 Org: User:
Start: 11/30/07 End: 09/30/10 Due: 09/30/11

Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males

Phase: N/A Priority: Normal
NCT ID: NCT02094781 Org: User:
Start: 12/31/13 End: 09/30/14 Due: 09/30/15

SB-742457 And Donepezil In Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00348192 Org: User:
Start: 05/31/06 End: - Due: -

Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A

Phase: N/A Priority: Normal
NCT ID: NCT01610414 Org: User:
Start: 07/13/12 End: 02/01/17 Due: 02/01/18

Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02660736 Org: User:
Start: 02/29/16 End: 08/31/16 Due: 08/31/17

Study to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT02019719 Org: User:
Start: 11/05/13 End: 08/06/14 Due: 08/06/15

A Study of Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT03614676 Org: User:
Start: 05/30/19 End: 07/27/21 Due: 07/27/22

RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00379769 Org: User:
Start: 04/30/01 End: 12/31/08 Due: 12/31/09

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05855200 Org: User:
Start: 08/01/23 End: 12/25/30 Due: 12/25/31

A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02207829 Org: User:
Start: 09/01/14 End: 06/15/15 Due: 06/15/16